// App-Quantinova.ai

CTNI-23 : IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA

Researchers

Presenter

  • C Mircea S Tesileanu

Principal Investigators

  • Sarah Erridge

  • Michael Vogelbaum

  • Anna Nowak

  • Marc Sanson

  • Alba Brandes

  • Wolfgang Wick

  • Paul Clement

  • Jean Baurain

  • Warren Mason

  • Helen Wheeler

  • Michael Weller

  • Kenneth Aldape

  • Pieter Wesseling

  • Johan M Kros

  • Vassilis Golfinopoulos

  • Thierry Gorlia

  • Brigitta Baumert

  • Martin van den Bent

Medical Centers

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Western General Hospital, Edinburgh, United Kingdom

  • Moffitt Cancer Center, Tampa, FL

  • Sir Charles Gairdner Hospital, Perth, Australia

  • Sorbonne Universites, Paris, France

  • AUSL-IRCCS Scienze Neurologiche, Bologna, Italy

  • University Clinic Heidelberg, Heidelberg, Germany

  • KU Leuven, Leuven, Belgium

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Department of Medical Oncology, Northern Sydney Cancer Center, Royal North Shore Hospital, Sydney, Australia

  • UniversitätsSpital Zürich - Klinik für Neurologie, Zurich, Switzerland

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • VU University Medical Center, Amsterdam, Netherlands

  • EORTC HQ, Brussels, Belgium

  • Cantonal hospital of Graubunden, Chur, Switzerland

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Australia

  • France

  • Italy

  • Germany

  • Belgium

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gliomas

  • Glioblastoma

Biomarkers

  • O-6-methylguanine DNA methyltransferase

  • Isocitrate dehydrogenase 1

  • Telomerase reverse transcriptase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved